Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
Afatinib With CT and RT for EGFR-Mutant NSCLC
ClinicalTrials.gov study NCT01553942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Olaparib + Sapacitabine in BRCA Mutant Breast Cancer
ClinicalTrials.gov study NCT03641755. IPD Sharing: NO. Countries: 1. Publications: 0.
Study for Treatment With TH-4000 (Tarloxotinib) in Epidermal Growth Factor Receptor (EGFR) Mutant, T790M-negative Non-small Cell Lung Cancer (NSCLC) Patients
ClinicalTrials.gov study NCT02454842. IPD Sharing: Not stated. Countries: 2. Publications: 0.
MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies
ClinicalTrials.gov study NCT02042989. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessing the Effect of DZD9008 on the Pharmacokinetics of the Cocktail Probes Representative for CYP3A4, P-gp, BCRP and OATP1B1 in Patients with EGFR or HER2 Mutant Advanced Non-small Cell Lung Cance
ClinicalTrials.gov study NCT05926180. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Nivolumab Verses Nivolumab and Ipilimumab Combination in EGFR Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03091491. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
ClinicalTrials.gov study NCT05536505. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC
ClinicalTrials.gov study NCT05773092. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer
ClinicalTrials.gov study NCT05514496. IPD Sharing: YES. Countries: 3. Publications: 0.
Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloprolif
ClinicalTrials.gov study NCT06284460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN).
ClinicalTrials.gov study NCT06105619. IPD Sharing: NO. Countries: 1. Publications: 0.
Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT07156604. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure
ClinicalTrials.gov study NCT06334757. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
ClinicalTrials.gov study NCT06749015. IPD Sharing: NO. Countries: 1. Publications: 0.
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy
ClinicalTrials.gov study NCT03952598. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
ClinicalTrials.gov study NCT07318324. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03127735. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Neoadjuvant Chemotherapy Sequentially Combined with Sintilimab in Resectable EGFR-Mutant NSCLC
ClinicalTrials.gov study NCT06688656. IPD Sharing: NO. Countries: 1. Publications: 0.
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06458257. IPD Sharing: YES. Countries: 1. Publications: 0.
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
ClinicalTrials.gov study NCT06586515. IPD Sharing: NO. Countries: 9. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.